HSD17B13
Protein-coding gene in the species Homo sapiens
HSD17B13 Identifiers Aliases HSD17B13 , NIIL497, SCDR9, SDR16C3, HMFN0376, hydroxysteroid (17-beta) dehydrogenase 13, hydroxysteroid 17-beta dehydrogenase 13External IDs OMIM : 612127 ; MGI : 2140804 ; GeneCards : HSD17B13 Gene location (Mouse ) Chr. Chromosome 5 (mouse) Band 5| 5 E5 Start 104,103,306 bp End 104,125,276 bp
Wikidata
17β-Hydroxysteroid dehydrogenase type 13 also known as 17β-HSD type 13 is an enzyme that in humans is encoded by the HSD17B13 gene .
17β-HSD13 is significantly up-regulated in the liver of patients with non-alcoholic fatty liver disease (NAFLD) and enhances lipogenesis .
Inhibitors
In 2023 the first potent and selective HSD17B13 inhibitor, BI-3231, was reported. The inhibitor meets the quality criteria of a 'Donated Chemical Probe' as defined by the Structural Genomics Consortium .